Wellorithm

Wellorithm sells AI-driven, at-home blood biomarker test kits that translate lab results into personalized supplement sachets and nutrition plans. Kits retail between $149 and $349, placing the brand in the mid-to-premium tier, and all orders are placed through the company’s direct-to-consumer website; refills ship on 30- or 90-day subscriptions. The company’s core IP is an algorithm that cross-references 35+ biomarkers with 250 clinical studies to auto-formulate micro-dosed nutrient blends delivered in daily, tear-open sachets. A single finger-prick collection card, postage-paid return mailer, and physician-reviewed digital report are bundled into every kit, positioning Wellorithm as a turnkey “lab-to-pill” wellness system rather than a generic supplement pack. Primary buyers are 28-45-year-old professionals who already track sleep, HRV, or macros and want objective data before adding pills to their routine. The brand appeals to quantified-self values—transparency, open data export, and evidence-based dosing—while avoiding one-size-fits-all multivitamins. Wellorithm competes with both DTC supplement subscription brands and consumer lab-testing services; it differentiates by closing the loop between diagnostic data and finished product in one platform, eliminating the need for users to interpret raw numbers or buy separate pills.